ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,413Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1942

$596K Total Retail Price of All Prescriptions

Rank: 39 out of 1942

547 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 11,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 534 494 1 2
LEVOTHYROXINE SODIUM 506 490 2 3
FUROSEMIDE 493 460 3 5
SIMVASTATIN 384 380 4 1
OMEPRAZOLE 362 342 5 4
AMLODIPINE BESYLATE 355 351 6 6
WARFARIN SODIUM 310 305 7 11
CITALOPRAM HBR 296 273 8 15
METOPROLOL TARTRATE 239 238 9 9
TAMSULOSIN HCL 233 227 10 29
SENNA PLUS 225 225 11 173
ATENOLOL 218 216 12 7
TRAZODONE HCL 217 216 13 24
HYDROCHLOROTHIAZIDE 216 213 14 8
METOPROLOL SUCCINATE 194 194 15 13
METFORMIN HCL 180 170 16 10
MAPAP 157 157 17 104
GABAPENTIN 150 138 18 16
ALLOPURINOL 131 121 19 26
HYDROCODONE-ACETAMINOPHEN 128 120 S3 20 12
ALENDRONATE SODIUM 124 112 21 21
CHLORHEXIDINE GLUCONATE 123 98 22 199
ATORVASTATIN CALCIUM 114 102 23 14
LANTUS 114 113 23 49
CLOPIDOGREL 104 104 25 55
POTASSIUM CHLORIDE 104 92 25 17
MIRTAZAPINE 102 102 27 38
GLIMEPIRIDE 100 98 28 53
DONEPEZIL HCL 93 93 29 30
PREDNISONE 92 91 30 27
ASPIRIN 91 91 31 214
ALBUTEROL SULFATE 91 91 31 152
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 90 31 22
SPIRIVA 89 78 34 57
ISOSORBIDE MONONITRATE ER 88 88 35 42
LOVASTATIN 84 58 36 32
RANITIDINE HCL 80 80 37 31
ROPINIROLE HCL 80 80 37 96
ADACEL 77 76 39 130
KLOR-CON M10 77 77 39 148
KLOR-CON M20 77 62 39 97
POLYETHYLENE GLYCOL 3350 76 58 42 28
CARBIDOPA-LEVODOPA 75 67 43 64
VENLAFAXINE HCL ER 73 73 44 70
FLUTICASONE PROPIONATE 72 69 45 37
RISPERIDONE 70 59 46 68
ABILIFY 68 51 47 155
DIGOXIN 68 56 47 40
VITAMIN D 64 64 49 150
OXYCONTIN 63 62 S2 50 84
OXYCODONE HCL 63 63 S2 50 52
PANTOPRAZOLE SODIUM 58 57 52 48
SERTRALINE HCL 58 54 52 20
OLANZAPINE 56 47 54 94
DIVALPROEX SODIUM ER 55 43 55 167
ARTIFICIAL TEARS 55 55 55 236
FLOVENT HFA 54 47 57 183
HALOPERIDOL 54 52 57 180
LOSARTAN POTASSIUM 54 54 57 18
QUETIAPINE FUMARATE 53 51 60 61
FINASTERIDE 53 49 60 86
TAB-A-VITE 53 53 60 318
PAROXETINE HCL 52 52 63 50
GLYBURIDE 51 49 R 64 69
HYDRALAZINE HCL 50 50 65 108
PLAVIX 50 50 65 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.